Diagnostics Development Highlighted In NIH Bioterrorism Agenda
This article was originally published in The Gray Sheet
Executive Summary
Microchip array-based platforms that include large numbers of microbial signatures should be pursued in the development of new diagnostics for bioterrorist threats, according to the National Institutes of Allergy and Infectious Diseases' most recent bioterrorism research agenda